BRPI1008227A2 - composição de glicocorticoide inalavel para uso na terapia de um paciente que sofre de asma severa e sem controle. - Google Patents

composição de glicocorticoide inalavel para uso na terapia de um paciente que sofre de asma severa e sem controle.

Info

Publication number
BRPI1008227A2
BRPI1008227A2 BRPI1008227A BRPI1008227A BRPI1008227A2 BR PI1008227 A2 BRPI1008227 A2 BR PI1008227A2 BR PI1008227 A BRPI1008227 A BR PI1008227A BR PI1008227 A BRPI1008227 A BR PI1008227A BR PI1008227 A2 BRPI1008227 A2 BR PI1008227A2
Authority
BR
Brazil
Prior art keywords
severe
therapy
patient suffering
uncontrolled asthma
glucocorticoid composition
Prior art date
Application number
BRPI1008227A
Other languages
English (en)
Inventor
BERNHARD MüLLER
Gerhard Scheuch
Philipp Kroneberg
Thomas Hofmann
Original Assignee
Activaero Gmbh Res & Devolopment
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42153807&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1008227(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Activaero Gmbh Res & Devolopment filed Critical Activaero Gmbh Res & Devolopment
Publication of BRPI1008227A2 publication Critical patent/BRPI1008227A2/pt
Publication of BRPI1008227A8 publication Critical patent/BRPI1008227A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI1008227A 2009-02-04 2010-02-03 composição de glicocorticoide inalável para uso na terapia de um paciente que sofre de asma severa e sem controle. BRPI1008227A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/365,754 US20100196483A1 (en) 2009-02-04 2009-02-04 Method for treatmentof severe and uncontrollable asthma
PCT/EP2010/051321 WO2010089330A1 (en) 2009-02-04 2010-02-03 Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma

Publications (2)

Publication Number Publication Date
BRPI1008227A2 true BRPI1008227A2 (pt) 2016-03-08
BRPI1008227A8 BRPI1008227A8 (pt) 2018-12-11

Family

ID=42153807

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008227A BRPI1008227A8 (pt) 2009-02-04 2010-02-03 composição de glicocorticoide inalável para uso na terapia de um paciente que sofre de asma severa e sem controle.

Country Status (22)

Country Link
US (1) US20100196483A1 (pt)
EP (2) EP3338782A1 (pt)
JP (1) JP5886630B2 (pt)
KR (1) KR20110122671A (pt)
CN (2) CN102307567A (pt)
AU (1) AU2010210183B2 (pt)
BR (1) BRPI1008227A8 (pt)
CA (1) CA2751443C (pt)
DK (1) DK2393477T3 (pt)
ES (1) ES2659328T3 (pt)
HU (1) HUE038553T2 (pt)
IL (1) IL213959A (pt)
MX (1) MX2011008200A (pt)
NO (1) NO2393477T3 (pt)
NZ (1) NZ594210A (pt)
PL (1) PL2393477T3 (pt)
PT (1) PT2393477T (pt)
RU (1) RU2519344C2 (pt)
SG (1) SG173538A1 (pt)
SI (1) SI2393477T1 (pt)
UA (1) UA102587C2 (pt)
WO (1) WO2010089330A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009079078A1 (en) 2007-12-14 2009-06-25 Labogroup S.A.S. Delivering aerosolizable food products
NZ628562A (en) 2012-03-09 2015-08-28 Vectura Gmbh Mixing channel for an inhalation device and inhalation device
WO2014012954A1 (en) * 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
US20140261474A1 (en) * 2013-03-15 2014-09-18 Aradigm Corporation Methods for inhalation of smoke-free nicotine
US8807131B1 (en) 2013-06-18 2014-08-19 Isonea Limited Compliance monitoring for asthma inhalers
EP3054948B1 (en) 2013-10-08 2020-08-12 AI Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
CA2936332A1 (en) * 2014-01-22 2015-07-30 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier)
BR112016022598A8 (pt) * 2014-04-04 2021-06-29 Ai Therapeutics Inc composição aerossol farmacêutica na forma de um pó seco para liberação pulmonar, forma de dosagem unitária, pacote farmacêutico, kit e uso
WO2015197798A1 (en) * 2014-06-25 2015-12-30 Optinose As Nasal administration
EP3209330B1 (en) 2014-10-07 2022-02-23 AI Therapeutics, Inc. An inhalable sirolimus formulation for the treatment of pulmonary hypertension
RU2611406C1 (ru) * 2015-09-03 2017-02-21 Общество с ограниченной ответственностью "Биосурф" (ООО "Биосурф") Способ лечения бронхиальной астмы
ES2894895T3 (es) 2016-07-08 2022-02-16 Trudell Medical Int Dispositivo de presión espiratoria positiva oscilante inteligente
ES2920151T3 (es) 2016-12-09 2022-08-01 Trudell Medical Int Nebulizador inteligente
MX2020007026A (es) 2018-01-04 2020-12-03 Trudell Medical Int Dispositivo de presión espiratoria positiva oscilante inteligente.
EP4021542A4 (en) 2019-08-27 2023-09-06 Trudell Medical International INTELLIGENT OSCILLATING POSITIVE EXPIRATORY PRESSURE DEVICE
US11593679B2 (en) * 2019-11-29 2023-02-28 Kpn Innovations, Llc. Method of and system for generating a longevity element and an instruction set for a longevity element plan
WO2022164616A1 (en) * 2021-01-29 2022-08-04 AsthmaTek, Inc. Systems and methods to determine a therapy regimen to treat asthma of a subject

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19720701A1 (de) * 1997-05-16 1998-11-19 Gsf Forschungszentrum Umwelt Vorrichtung zur Applikation eines Medikament-Aerosols über die Lunge
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
DE19851279B4 (de) * 1998-06-17 2006-05-24 GSF - Forschungszentrum für Umwelt und Gesundheit GmbH Vorrichtung zum gesteuerten inhalatorischen Einbringen von dosierten Medikamenten in die Lunge
DE19912265A1 (de) * 1999-03-18 2000-09-21 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zur Bereitstellung einer konstanten Medikamenten-Dosis für eine inhalatorische Applikation mit niedrigem Inhalationsfluß
DE19912461B4 (de) * 1999-03-19 2006-07-20 GSF - Forschungszentrum für Umwelt und Gesundheit GmbH Vorrichtung zur Flußbegrenzung bei niedrigen Differenzdrücken
DE10013093B4 (de) * 2000-03-17 2005-12-22 Inamed Gmbh Vorrichtung zur kontrollierten Inhalation therapeutischer Aerosole
DE10029119B4 (de) * 2000-06-14 2005-12-22 Institut für Aerosol Medizin InAMed GmbH Inhalationsvorrichtung
DE10123749A1 (de) * 2001-05-16 2002-12-12 Inamed Gmbh Vorrichtung zum Verabreichen von Aerosolen
CN1976679B (zh) * 2003-12-31 2011-08-31 锡德克斯药物公司 含有磺基烷基醚环糊精以及皮质甾类的吸入制剂
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
ES2414869T3 (es) * 2005-03-08 2013-07-23 Activaero Gmbh Dispositivo de inhalación
DE502005001542D1 (de) * 2005-07-06 2007-10-31 Activaero Gmbh Regelbares Ventil und Inhalationsvorrichtung
KR100802292B1 (ko) * 2006-07-21 2008-02-11 동부일렉트로닉스 주식회사 마스크 및 이를 이용한 마이크로 렌즈 제작 방법
CN101795565A (zh) * 2007-06-28 2010-08-04 锡德克斯药物公司 皮质类固醇水溶液的鼻部和眼部给药
CN102186458A (zh) * 2008-10-14 2011-09-14 艾克蒂维罗有限责任公司 治疗慢性阻塞性肺病及其它肺疾病的方法

Also Published As

Publication number Publication date
UA102587C2 (ru) 2013-07-25
EP3338782A1 (en) 2018-06-27
CN102307567A (zh) 2012-01-04
HUE038553T2 (hu) 2018-10-29
IL213959A (en) 2015-05-31
NO2393477T3 (pt) 2018-05-26
SI2393477T1 (en) 2018-04-30
JP5886630B2 (ja) 2016-03-16
WO2010089330A1 (en) 2010-08-12
CA2751443A1 (en) 2010-08-12
AU2010210183A1 (en) 2011-07-28
IL213959A0 (en) 2011-08-31
JP2012516873A (ja) 2012-07-26
BRPI1008227A8 (pt) 2018-12-11
AU2010210183B2 (en) 2014-09-11
EP2393477A1 (en) 2011-12-14
NZ594210A (en) 2013-09-27
US20100196483A1 (en) 2010-08-05
RU2519344C2 (ru) 2014-06-10
KR20110122671A (ko) 2011-11-10
PL2393477T3 (pl) 2018-06-29
SG173538A1 (en) 2011-09-29
CN104306360A (zh) 2015-01-28
DK2393477T3 (en) 2018-04-09
PT2393477T (pt) 2018-02-14
CA2751443C (en) 2018-03-20
EP2393477B1 (en) 2017-12-27
RU2011135824A (ru) 2013-03-10
ES2659328T3 (es) 2018-03-14
MX2011008200A (es) 2011-10-21

Similar Documents

Publication Publication Date Title
BRPI1008227A2 (pt) composição de glicocorticoide inalavel para uso na terapia de um paciente que sofre de asma severa e sem controle.
HK1202558A1 (en) Compositions and methods for the therapy and diagnosis of influenza
CL2007002791A1 (es) Compuestos derivados de sulfonamida; composicion farmaceutica que comprende a estos compuestos; combinacion farmaceutica que comprende a estos compuestos; y su uso para tratar trastornos, enfermedades y afecciones seleccionadas de asma, broncoconstri
IL236892B (en) A combination of an immunoconjugate and an antibody for use in medical treatment, a pharmaceutical preparation and a kit containing it
UY31686A1 (es) Nueva dosificacion y formulacion
CL2012003290A1 (es) Metodo para preparar una composicion enriquecida en igg a partir de plasma; composicion acuosa de igg; composicion farmaceutica que comprende dicha composicion acuosa; uso de dicha composicion para tratar enfermedad autoinmune o infeccion aguda
EP2259782A4 (en) PHARMACEUTICAL FORMULATIONS OF RESVERATROL AND METHOD FOR THEIR USE IN THE TREATMENT OF CELL DISEASES
BR112012008854A2 (pt) combinação, kit de combinação, uso de uma combinação, composição farmacêutica, e, método para tratar câncer em um ser humano
CL2007002121A1 (es) Compuestos derivados de pirazoles, activadores de glucoquinasa; proceso de preparacion de dichos compuestos; composicion farmaceutica que comprende dichos compuestos; y uso para el tratamiento de enfermedades y/o trastornos metabolicos, tal como diab
EP2437743A4 (en) OPHTHALMIC FORMULATIONS OF FLUTICASONE AND METHODS OF USE
BRPI1013288A2 (pt) uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto
BRPI0908503A2 (pt) partícula com um diâmetro menor que 2mm, e, composição para o tratamento de tecidos
GT201400182A (es) Formulaciones farmacéuticas novedosas
EP2300028A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING EFFICIENT HUANGLIAN (COPTIS SINENSIS) AND KU DING CHA EXTRACTS AS HYPOLIPEMANTS
UY31687A1 (es) Nueva dosificacion y formulacion
BRPI1009781A2 (pt) compostos para o tratamento de distúrbios metabólicos, composição farmacêutica que os compreende e uso dos mesmos
ZA201403431B (en) Pharmaceutical compositions and methods of use of 4-pregenen-11b-21-triol-3,20-dione derivatives
EP2464383A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF FLU
EP2370068A4 (en) METHOD AND COMPOSITIONS FOR DELIVERING MEDICAMENTS TO THE LUNG
IL218656A (en) Preparations containing pancreatic enzyme and use in the preparation of a drug for the treatment of pancreatitis and pancreatic failure
EP2049662A4 (en) METHODS AND COMPOSITIONS FOR INCREASING REPLICATION CAPACITY OF A FLU VIRUS
HK1197235A1 (zh) 二氫吡唑、其藥物組合物及其治療生育障礙的用途
CL2008000047A1 (es) Compuestos derivados de sulfonamida; procedimiento de preparacion; composicion farmaceutica que contiene a dichos compuestos; y su uso en el tratamiento y profilaxis de aterotrombosis y asma.
EP2377934A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF TUMOR AND ASTHMA
BRPI1008276A2 (pt) processo para a preparação e uso de uma composição

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: ACTIVAERO GMBH (DE)

B25G Requested change of headquarter approved

Owner name: ACTIVAERO GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: VECTURA GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL